Peanut for anaphylaxis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jul 2014: Trial registered, NCT02203799
  2. 31 Jul 2014: Trial started, NCT02203799

The trials

NCT02203799: Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour)

State
Completed
Phase
Phase 1
People
15 taking part
Started
31 Jul 2014
Primary completion
11 Feb 2020
Arms
Peanut Oral Immunotherapy (POIT)
Results
Posted on the registry
  1. 30 Jul 2014: Trial registered
  2. 31 Jul 2014: Trial started
  3. 11 Feb 2020: Trial completed
  4. 19 Jan 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Also known as Open label peanut OIT, Peanut OIT, Peanut Oral Immunotherapy (POIT), Peanut Oral Immunotherapy - Peanut Flour.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.